Emmie de Wit

From Wikipedia, the free encyclopedia
Emmie de Wit
Emmie de Wit.png
NationalityDutch
Alma materErasmus University Rotterdam (PhD)
Scientific career
FieldsViral pathogenesis
InstitutionsRocky Mountain Laboratories

Emmie de Wit is a Dutch-American virologist. She is chief of the molecular pathogenesis unit at the Rocky Mountain Laboratories. Her research combines pathogenesis studies with detailed molecular analyses to identify molecular determinants of severe respiratory tract disease within the virus and the host.

Education[]

Emmie de Wit is from the Netherlands.[1] She received her Ph.D. in virology in 2006 from Erasmus University Rotterdam. Her research focused on the replication, pathogenesis and transmission of influenza A virus.[2] Her dissertation was titled Molecular determinants of influenza A virus replication and pathogenesis.[3]

Career[]

In 2009, de Wit moved to Heinz Feldmann's Laboratory of Virology at the Rocky Mountain Laboratories (RML) to research in the biosafety level 4 laboratory. Here, she focused on the pathogenesis of and countermeasures against Nipah virus, the Middle East Respiratory Syndrome Coronavirus and the 1918 H1N1 influenza A virus (Spanish flu).[2] In 2012, she received a Fellows Award for Research Excellence (FARE) for her research on modeling the transmission cycle of the deadly Nipah virus.[4] From 2014 to 2015, de Wit spent 4 months in a field lab in Monrovia, Liberia in charge of patient diagnostics for several Ebola Treatment Units in the area, to help contain the Ebola virus epidemic in Liberia. Currently, de Wit's research aims to combine pathogenesis studies with detailed molecular analyses to identify molecular determinants of severe respiratory tract disease within the virus and the host. She is chief of the molecular pathogenesis unit at RML.[2]

References[]

  1. ^ Bichell, Rae Ellen (2016-12-04). "What It's Like To Handle The Nastiest Pathogens As Your Day Job". NPR. Retrieved 2020-03-29.
  2. ^ Jump up to: a b c "Emmie de Wit, Ph.D. | NIH: National Institute of Allergy and Infectious Diseases". www.niaid.nih.gov. Retrieved 2020-03-29.
  3. ^ Wit, Emmie de (2006). Molecular determinants of influenza A virus replication and pathogenesis (Thesis). OCLC 150315522.
  4. ^ Mott, Meghan; NIAAA (2013-05-13). "The Perils of Nipah Virus and Ischemic Stroke". NIH Intramural Research Program. Retrieved 2020-03-29.
Public Domain This article incorporates public domain material from websites or documents of the National Institutes of Health.
Retrieved from ""